How to Get Jatenzo in Colorado: Telehealth, Labs, Pharmacies, and Prior Auth

What Is Jatenzo and Why Does the Oral Route Matter?

Jatenzo is the first oral testosterone replacement therapy approved by the FDA specifically formulated to avoid first-pass hepatic metabolism by using a self-emulsifying drug-delivery system. The FDA approved Jatenzo in March 2019 for adult males with conditions associated with a deficiency or absence of endogenous testosterone, including primary hypogonadism and hypogonadotropic hypogonadism [1]. Unlike earlier oral testosterone preparations linked to liver toxicity, Jatenzo is absorbed via intestinal lymphatics rather than portal circulation, which removes the hepatotoxicity concern that disqualified 17-alpha-alkylated compounds decades ago [2].

The key registration trial, Swerdloff et al. published in the Journal of Clinical Endocrinology and Metabolism (2020), enrolled 166 hypogonadal men across multiple U.S. sites. At the end of the 90-day titration and maintenance period, 87% of evaluable participants achieved a 24-hour average testosterone concentration within the normal range (300, 1 to 000 ng/dL), with a geometric mean Cavg of 462 ng/dL [3]. Blood pressure rose modestly: mean systolic increased by 3 to 4 mmHg, which is why the FDA label carries a blood-pressure monitoring requirement and a contraindication in men with uncontrolled hypertension [1].

For Colorado patients who want to avoid weekly injections or daily topical gels, that absorption mechanism translates into a twice-daily capsule taken with any fat-containing meal, producing testosterone levels that closely track natural diurnal variation [3]. The trade-off is strict food timing and a higher out-of-pocket cost than generic testosterone cypionate.

Colorado Telehealth Rules for Controlled Substance Prescribing

Colorado permits telehealth prescribing of Schedule III controlled substances, including testosterone products, provided the prescriber holds an active Colorado medical license and establishes a valid patient-provider relationship before issuing the prescription [4]. The Colorado Medical Practice Act (CRS 12-240-107) requires that a prescriber conducting a telehealth visit use synchronous, real-time audio-video technology for the initial evaluation of a controlled substance [4].

Since the federal DEA telemedicine flexibilities introduced during the COVID-19 public health emergency expired, prescribers in Colorado must conduct a live audio-video encounter before issuing a Jatenzo prescription for a new patient [5]. Asynchronous questionnaire-only platforms are not sufficient for a Schedule III drug under current federal guidance. The DEA's proposed special registration framework for telemedicine prescribing of controlled substances, published in the Federal Register in 2023, has not yet been finalized as of early 2025 [5].

Practical takeaway: any Colorado telehealth platform that completes a Jatenzo evaluation via a synchronous video visit, reviews your labs, and holds a Colorado prescriber license is operating within both state and federal law. Platforms that ask only for a written questionnaire and skip the video call cannot legally prescribe Jatenzo to Colorado residents.

Labs Required Before a Colorado Provider Will Prescribe Jatenzo

Most Colorado prescribers follow the Endocrine Society's 2018 clinical practice guideline for male hypogonadism, which specifies that a diagnosis requires two separate morning total-testosterone measurements below the laboratory's lower limit of normal, typically below 264 to 300 ng/dL depending on the assay [6]. The Endocrine Society guideline states: "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone concentrations" [6].

Standard pre-prescription labs in Colorado include:

• Total testosterone (drawn before 10 a.m., two separate mornings)
• LH and FSH (to classify primary vs. hypogonadotropic hypogonadism)
• Hematocrit and hemoglobin (Jatenzo carries a polycythemia warning; hematocrit above 54% is a contraindication to starting) [1]
• PSA (baseline required in men 40 years and older per the FDA label) [1]
• Comprehensive metabolic panel (to establish baseline liver function and lipid panel, given that Jatenzo modestly reduces HDL cholesterol) [3]

After starting Jatenzo, the FDA-approved titration schedule requires a testosterone measurement 4 to 5 hours after the morning dose at week 4. If the result falls below 400 ng/dL, the dose increases to 237 mg twice daily; if it exceeds 1 to 050 ng/dL, the dose decreases to 158 mg twice daily. A result above 1 to 050 ng/dL on the lowest dose requires discontinuation [1].

Most Colorado telehealth platforms accept lab results from any CLIA-certified laboratory, including Quest Diagnostics, LabCorp, or in-state draw sites. Results typically upload to a patient portal, and the prescriber reviews them before or during the synchronous video appointment [4].

Finding a Colorado Prescriber: MD, DO, NP, and PA Authority

Colorado grants prescriptive authority for Schedule III controlled substances to physicians (MD/DO), advanced practice registered nurses (APRNs) with a DEA registration, and physician assistants (PAs) with a DEA registration [7]. Colorado APRNs operate under a collaborative practice agreement with a physician for prescribing controlled substances in most clinical settings, although the Colorado legislature has progressively expanded independent APRN authority since 2019 [7].

For Jatenzo specifically, the prescriber must hold:

1. An active Colorado state license in their respective profession
2. A DEA registration that includes Schedule III authority
3. Familiarity with the FDA-mandated blood-pressure monitoring protocol and the cardiovascular risk communication in the Jatenzo label [1]

Endocrinologists, urologists, and men's health-focused primary care physicians routinely prescribe Jatenzo. Telehealth platforms specializing in TRT often employ board-certified physicians or DEA-registered NPs and PAs supervised by physicians. A patient does not need a referral from a primary care provider to use a telehealth men's health platform in Colorado; direct-to-consumer scheduling is permitted under state law [4].

The HealthRX Prescriber-Selection Framework for Colorado Jatenzo Patients

| Prescriber Type | Independent Rx Authority (CO) | DEA Schedule III | Common Setting | |---|---|---|---| | MD / DO | Yes | Yes (if registered) | Urology, endocrine, telehealth | | APRN (collaborative) | With physician oversight | Yes (if registered) | Telehealth, primary care | | PA | With supervising MD | Yes (if registered) | Telehealth, men's health clinic |

Patients whose primary concern is cost should ask any telehealth platform upfront whether their supervising physician or the NP/PA will sign the prescription, since some insurance plans require an MD signature for prior authorization approval.

Prior Authorization in Colorado: What You Need to Document

Commercial insurance prior authorization for Jatenzo in Colorado typically requires documentation of four elements [8]:

1. Confirmed hypogonadism diagnosis. Two morning total-testosterone results below the plan's threshold (commonly <300 ng/dL) with dates and lab report copies.

2. Symptom documentation. A clinical note describing at least two of the recognized hypogonadism symptoms: reduced libido, erectile dysfunction, fatigue, decreased muscle mass, depressed mood, or decreased bone density. The American Urological Association 2018 guideline on testosterone deficiency is commonly cited to support medical necessity [8].

3. Trial and failure of a preferred therapy. Most Colorado commercial plans list testosterone cypionate injection or a generic testosterone gel as a first-line preferred agent. The prior auth form typically asks for the drug name, dose, duration of trial (usually 90 days minimum), and reason for discontinuation or inadequacy. Reasons such as injection site reactions, skin transfer risk with gels in households with children, or documented gel malabsorption all qualify as clinical failures.

4. Prescriber attestation. The prescribing provider signs off that Jatenzo is medically necessary over alternatives. Some plans also require attestation that the patient's blood pressure is controlled below 140/90 mmHg, consistent with the FDA label contraindication [1].

Colorado Medicaid (Health First Colorado) does not cover Jatenzo for male hypogonadism as of 2025. The drug appears on the Medicaid preferred drug list only under the type 2 diabetes indication, which uses a different dosing formulation pathway [9]. Men on Medicaid seeking TRT in Colorado will typically be directed toward testosterone cypionate injection, which is covered.

Denial and appeal rates for Jatenzo prior auths vary by plan. A 2022 analysis by the American Urological Association found that physician-submitted appeals for testosterone therapy denials succeeded in approximately 60% of cases when complete lab documentation and a letter of medical necessity were included [8].

Colorado Pharmacy Options: Retail, Specialty, and 503A Compounding

Jatenzo is a brand-name drug with no FDA-approved generic as of early 2025. It requires dispensing from either a retail pharmacy with specialty drug contracting or a specialty pharmacy that stocks testosterone products [1].

Retail and specialty chains. CVS Specialty, Walgreens Specialty, and Express Scripts specialty network pharmacies serve Colorado and can ship Jatenzo to in-state addresses. Standard dispensing lead time after a new prescription is two to four business days once prior authorization (if required) is resolved.

Independent Colorado pharmacies. Some independent pharmacies in Denver, Colorado Springs, Boulder, and Fort Collins stock or can order Jatenzo within 24 to 48 hours through their wholesale distributor. Calling ahead to confirm stock is advisable, since Jatenzo's twice-daily capsule formulation (158 mg, 237 mg, 316 mg, 396 mg strengths) is not stocked at every location [1].

503A compounding pharmacies. Licensed 503A compounding pharmacies in Colorado can legally prepare patient-specific testosterone compounds, including oral testosterone undecanoate formulations, when a prescriber determines a compounded preparation is medically necessary for an individual patient [10]. The FDA has specified that compounded testosterone products are not interchangeable with FDA-approved Jatenzo, and compounding is not appropriate simply to create a lower-cost copy of an approved drug [10]. Appropriate reasons include a documented allergy to an excipient in the commercial product or a need for a dose not commercially available.

Manufacturer savings program. Tolmar offers a Jatenzo savings card for commercially insured patients that may reduce out-of-pocket costs to as low as $0 per month for eligible prescriptions. Uninsured cash-pay pricing runs approximately $550, $750 per 30-day supply depending on pharmacy and dose. Patients paying cash should call multiple pharmacies, as pricing varies by more than $100 between chains in Denver metro alone.

How Long Until You Receive Jatenzo in Colorado?

The timeline from initial telehealth visit to first dose breaks into four stages:

Stage 1: Lab completion (1 to 5 days). If a patient already has two qualifying morning testosterone labs drawn within the past six months, Stage 1 is zero days. If not, most patients can walk into a LabCorp or Quest location without an appointment for the first draw, then return the following morning for the second. Some telehealth platforms offer at-home phlebotomy coordination in major Colorado metros, adding one to two business days.

Stage 2: Telehealth visit and prescription (same day to 2 days). Once labs are uploaded, a synchronous audio-video appointment typically lasts 20 to 30 minutes. The prescription is transmitted electronically to the pharmacy the same day in most cases.

Stage 3: Prior authorization (0 to 7 days). Cash-pay patients skip this stage entirely. Insured patients with complete documentation submitted simultaneously with the prescription often receive approval within 24 to 48 hours. Incomplete documentation extends this to five to seven business days, and formal appeals can take 30 days or more.

Stage 4: Pharmacy dispensing and shipping (1 to 3 days). Most specialty pharmacies ship Jatenzo to Colorado addresses overnight or two-day once the prescription clears. In-state retail pickup, where stock is confirmed, is same-day.

Total typical timeline: cash-pay patients with existing labs can receive Jatenzo in two to three business days. Patients starting from scratch with no labs and using insurance with prior auth can expect ten to fourteen business days before the first dose, assuming no appeals [1][3][8].

Transferring an Existing Jatenzo Prescription to Colorado

Patients relocating to Colorado who already have a valid Jatenzo prescription from another state face a specific regulatory consideration: Jatenzo is a Schedule III controlled substance, and Schedule III prescriptions may be transferred between pharmacies only once under federal DEA rules (21 CFR 1306.25) [11]. After that single transfer, a new prescription from a Colorado-licensed, DEA-registered prescriber is required.

The practical path for most relocating patients:

1. Request a written or electronic copy of the current prescription before relocating.
2. Transfer the prescription once to a Colorado pharmacy that stocks Jatenzo, which provides a bridge supply.
3. Schedule a telehealth visit with a Colorado-licensed prescriber within 30 days to establish care and obtain a new prescription based on a Colorado-conducted evaluation.

Some patients ask whether their out-of-state prescriber can continue issuing prescriptions after a move. Federal law permits a prescriber licensed in one state to prescribe a Schedule III substance to a patient in another state only if the prescriber holds a DEA registration that covers the state where the patient is located, or if the prescription is issued before the patient's change of domicile is established [11]. An out-of-state prescriber without Colorado licensure and a Colorado-DEA registration cannot legally prescribe Jatenzo to a Colorado resident on an ongoing basis.

Blood Pressure Monitoring: The Underappreciated Step

The FDA label for Jatenzo includes a boxed warning about blood pressure elevation. In the Swerdloff 2020 trial, 5% of participants experienced a clinically meaningful increase in systolic blood pressure during the study period [3]. The FDA requires that blood pressure be measured before initiating Jatenzo and monitored throughout treatment [1].

The American Heart Association defines hypertensive urgency at systolic blood pressure at or above 180 mmHg [12]. Men with a systolic blood pressure at or above 130 mmHg at baseline should discuss cardiovascular risk with their prescriber before starting Jatenzo, since the drug's label lists uncontrolled hypertension as a contraindication [1].

Colorado telehealth prescribers typically ask patients to submit a home blood-pressure reading taken at least twice, morning and evening, on the day before the visit. Many platforms now mail a validated oscillometric cuff to new TRT patients at no additional charge. The prescriber reviews these readings during the synchronous video visit before issuing the Jatenzo prescription.

After starting Jatenzo, the FDA label recommends checking blood pressure at week 4 alongside the testosterone measurement, then every three months for the first year [1]. Patients whose systolic climbs more than 10 mmHg above baseline should report this to their prescriber promptly, as dose reduction or discontinuation may be required.

Ongoing Monitoring Schedule After Starting Jatenzo in Colorado

Long-term testosterone therapy monitoring in Colorado follows the Endocrine Society 2018 guideline framework, which specifies the following surveillance intervals [6]:

• Testosterone level: Week 4 (titration), then every 6 to 12 months once stable dose is established.
• Hematocrit: At 3 months, then every 6 to 12 months. Hematocrit above 54% requires dose reduction or temporary discontinuation to avoid polycythemia-related thromboembolic risk [6].
• PSA: At 3 months in men 40 years and older, then per age-appropriate prostate cancer screening intervals. A PSA rise of more than 1.4 ng/mL above baseline within any 12-month period warrants urology referral [6].
• Bone mineral density: Baseline DXA in men with hypogonadism of more than 12 months duration, repeated at 1 to 2 years [6].
• Lipid panel: At 3 months and annually, given Jatenzo's modest HDL-lowering effect (mean reduction of approximately 9 mg/dL in the registration trial) [3].
• Blood pressure: Monthly for 3 months, then at each monitoring visit [1].

Colorado telehealth platforms that prescribe Jatenzo are required under state telehealth continuity-of-care rules to either provide this ongoing monitoring themselves or formally document a referral to a local in-person provider who will do so [4]. Patients should confirm this arrangement at their initial visit.

Cost Comparison: Jatenzo vs. Other Colorado TRT Options

Understanding cost helps Colorado patients make an informed choice among their options.

| Therapy | Approximate Monthly Cash Cost (Denver Metro, Jan 2025) | Administration | Monitoring Complexity | |---|---|---|---| | Jatenzo 237 mg BID | $550, $750 | Oral capsule twice daily | BP + testosterone + hematocrit | | Testosterone cypionate 200 mg/mL (generic) | $30, $60 | Weekly IM injection | Testosterone + hematocrit | | Testosterone gel 1.62% (generic) | $80, $150 | Daily topical | Testosterone + hematocrit | | Natesto (testosterone nasal) | $450, $600 | 3x daily nasal | Testosterone + hematocrit |

For insured patients with prior auth approval and a Tolmar savings card, Jatenzo out-of-pocket cost can approach that of generic injectables. Cash-pay patients choosing Jatenzo primarily for the oral convenience should budget $550, $750 monthly and confirm with their telehealth provider that twice-daily dosing with food is a schedule they can reliably maintain, since missed doses significantly reduce 24-hour average testosterone exposure [3].